Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael E Pollock

Showing results (141-150 of 234) with videos related to

Pageof 24
Sort By:
Oncogene|July 12, 2020
β-catenin S45F mutation results in apoptotic resistanceDanielle Braggio, Abeba Zewdu, Priya Londhe, et al.
Oncotarget|September 20, 2014
Gankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcomaJu-Ae Hwang, Heung-Mo Yang, Doo-Pyo Hong, et al.
Cancer|April 30, 2009
Clinical outcomes of molecularly confirmed clear cell sarcoma from a single institution and in comparison with data from the Surveillance, Epidemiology, and End Results registryDan G Blazer, Alexander J Lazar, Yan Xing, et al.
Annals of Surgery|May 21, 2010
Angiosarcoma: clinical and molecular insightsGuy Lahat, Asha R Dhuka, Hen Hallevi, et al.
Journal of Extracellular Vesicles|August 31, 2022
In situ hybridization to detect DNA amplification in extracellular vesiclesLucia Casadei, Patricia Sarchet, Fernanda Costas C de Faria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2012
Survivin is a viable target for the treatment of malignant peripheral nerve sheath tumorsMarkus P Ghadimi, Eric D Young, Roman Belousov, et al.
Molecular Cancer Therapeutics|August 1, 2012
Targeting the PI3K/mTOR axis, alone and in combination with autophagy blockade, for the treatment of malignant peripheral nerve sheath tumorsMarkus P Ghadimi, Gonzalo Lopez, Keila E Torres, et al.
Journal of Surgical Oncology|December 31, 2013
Assessment of multimodality therapy use for extremity sarcoma in the United StatesKaren L Sherman, Jeffrey D Wayne, Jeanette Chung, et al.
Annals of Surgery|May 29, 2009
Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcomeChangye Zou, Kerrington D Smith, Jun Liu, et al.
Sarcoma|February 24, 2015
Analysis of the intratumoral adaptive immune response in well differentiated and dedifferentiated retroperitoneal liposarcomaWilliam W Tseng, Shruti Malu, Minying Zhang, et al.
Pageof 24

Showing results (141-150 of 234) with videos related to

Sort By:
Pageof 24
Oncogene|July 12, 2020
β-catenin S45F mutation results in apoptotic resistanceDanielle Braggio, Abeba Zewdu, Priya Londhe, et al.
Oncotarget|September 20, 2014
Gankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcomaJu-Ae Hwang, Heung-Mo Yang, Doo-Pyo Hong, et al.
Cancer|April 30, 2009
Clinical outcomes of molecularly confirmed clear cell sarcoma from a single institution and in comparison with data from the Surveillance, Epidemiology, and End Results registryDan G Blazer, Alexander J Lazar, Yan Xing, et al.
Annals of Surgery|May 21, 2010
Angiosarcoma: clinical and molecular insightsGuy Lahat, Asha R Dhuka, Hen Hallevi, et al.
Journal of Extracellular Vesicles|August 31, 2022
In situ hybridization to detect DNA amplification in extracellular vesiclesLucia Casadei, Patricia Sarchet, Fernanda Costas C de Faria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2012
Survivin is a viable target for the treatment of malignant peripheral nerve sheath tumorsMarkus P Ghadimi, Eric D Young, Roman Belousov, et al.
Molecular Cancer Therapeutics|August 1, 2012
Targeting the PI3K/mTOR axis, alone and in combination with autophagy blockade, for the treatment of malignant peripheral nerve sheath tumorsMarkus P Ghadimi, Gonzalo Lopez, Keila E Torres, et al.
Journal of Surgical Oncology|December 31, 2013
Assessment of multimodality therapy use for extremity sarcoma in the United StatesKaren L Sherman, Jeffrey D Wayne, Jeanette Chung, et al.
Annals of Surgery|May 29, 2009
Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcomeChangye Zou, Kerrington D Smith, Jun Liu, et al.
Sarcoma|February 24, 2015
Analysis of the intratumoral adaptive immune response in well differentiated and dedifferentiated retroperitoneal liposarcomaWilliam W Tseng, Shruti Malu, Minying Zhang, et al.
Pageof 24